Back

Feasibility and clinical outcomes of 48 mm drug eluting stents in management of patients with coronary artery disease

29 August 2022 (12:15 - 12:55)
Organised by:
Congress Presentation Part of: Coronary artery disease - Revascularisation 4 Revascularisation ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Assistant Professor Ahmed El Amrawy

Alexandria Faculty of Medicine, Alexandria (Egypt)

5 More presentations in this session

Presentation thumbnail
The long-term cardiac events after coronary bifurcation stenting with second-generation drug-eluting stents in elderly patients are comparable to those of younger patients
Professor J. Park (Seoul, KR)
Abstract Slides
Presentation thumbnail
In-hospital and long-term outcomes of percutaneous coronary interventions for chronic total occlusions in patients with contrast-associated acute kidney injury
Doctor P. Tajti (Bonyhad, HU)
Abstract Slides
Presentation thumbnail
ST Segment myocardial infarction due to totally occluded unprotected left main coronary artery (TOULM): an insight from nationwide database
Doctor A. Arabi (Doha, QA) Doctor I. Rafie (Doha, QA)
Abstract Slides
Presentation thumbnail
PCI of chronic total occlusions: what is the clinical benefit and impact on quality of life?
Doctor H. Costa (Faro, PT)
Abstract Slides
Presentation thumbnail
Clinical outcomes of percutaneous coronary intervention and rotational atherectomy using second generation drug eluting stents: a Korean multicentre analysis
Doctor K. Kim (Seoul, KR)
Abstract Slides

Access the full session

Session thumbnail
Coronary artery disease - Revascularisation 4

The Event

Event poster

ESC Congress 2022

29 August 2022 12:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources